The LMA CTrach™ in morbidly obese and lean patients undergoing gynecological procedures: a comparative study

J Anesth. 2010 Dec;24(6):849-53. doi: 10.1007/s00540-010-1022-2. Epub 2010 Oct 1.

Abstract

Purpose: The tracheas of obese patients may be more difficult to intubate than those of normal-weight patients. The aim of this study was to compare the airway management quality in morbidly obese and lean patients with use of the LMA CTrach.

Methods: After Ethics Committee approval, 60 adult patients (30 morbidly obese patients with body mass index >40 kg/m² and 30 lean patients with body mass index <30 kg/m²) scheduled to undergo gynecological surgery were enrolled in this prospective study. The induction of anesthesia was standardized using propofol, fentanyl, and rocuronium. Ventilation and intubation success rates, time taken to achieve successful ventilation, and intubation through the CTrach and airway complications were recorded.

Results: The CTrach was successfully inserted and adequate ventilation through the CTrach was achieved in 59 patients (98%). Only 1 patient in the lean group was not able to ventilate through the CTrach. We were successful in endotracheal intubation, either under vision or blind, in 56 patients (93%). We were able to view the larynx in 51 patients (85%). Total intubation time was significantly longer in morbidly obese patients, 69 (311) s, than in lean patients, 33 (107) s [median (range)] (P < 0.001).

Conclusions: We concluded that the time to intubate the trachea in obese patients was significantly longer than in lean patients when the LMA CTrach was used.

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Adult
  • Body Mass Index
  • Female
  • Gynecologic Surgical Procedures*
  • Humans
  • Hypnotics and Sedatives
  • Intubation, Intratracheal
  • Laryngeal Masks*
  • Larynx / anatomy & histology
  • Larynx / injuries
  • Midazolam
  • Middle Aged
  • Obesity, Morbid / complications*
  • Pain, Postoperative / epidemiology
  • Preanesthetic Medication
  • Prospective Studies
  • Respiration, Artificial

Substances

  • Hypnotics and Sedatives
  • Midazolam